Search results
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
Zacks via Yahoo Finance· 2 weeks agoVertex (VRTX) begins rolling NDA submission for its investigational non-opioid candidate,...
Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year
Zacks via Yahoo Finance· 5 months agoVertex Pharmaceuticals Incorporated VRTX enjoys a dominant position in the cystic fibrosis (CF)...
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
Zacks via Yahoo Finance· 1 month agoVertex Pharmaceuticals Incorporated VRTX enjoys a dominant position in the cystic fibrosis (CF)...
IBD 50 Stocks To Watch: Vertex Pharmaceuticals In Buy Zone As Firm Gets On A Roll
Investor's Business Daily· 1 year agoBiotech stock Vertex Pharmaceuticals is in the buy zone of a base. Vertex stock is Tuesday's IBD 50...
Vertex, the ultimate event for 2D and 3D artists, returns in 2024
Creative Bloq via Yahoo News· 5 months agoVertex; a logo on a complex designed background. It's been a long time coming but our Vertex...
IBD 50 Stocks To Watch: Vertex Pharmaceuticals Nears Buy Point; Institutions Scoop Up Shares
Investor's Business Daily· 1 year agoBiotech stock Vertex Pharmaceuticals is forming a base and nearing a buy point. VRTX stock is...
IBD 50 Stocks To Watch: Vertex Approaches Buy Point As Market Attempts Rally
Investor's Business Daily· 2 years agoDrug stock Vertex Pharmaceuticals is working on a new base just as the stock market attempts to...
Vertex builds case for non-opioid pain drug ahead of key study readouts
BioPharma Dive via Yahoo Finance· 5 months agoThe closely watched medicine showed promise treating a form of chronic nerve pain, with the results...
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has been generating billion-dollar revenue for years, thanks...
How IBD Stock Of The Day Vertex Is Stacking Up Billions In Potential Sales
Investor's Business Daily· 1 year agoVertex Pharmaceuticals is Wednesday's IBD Stock Of The Day. As the biotech eyes several blockbuster...